PRESS PLUS 5 MG + 20 MG CAP DURA CT BL AL PLAS TRANS X 30
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1097401450080 -
GGREM
504110909113312 -
Código de barras
7896112471165
O que a fonte publica
- Detentor do registro
- BIOLAB SANUS FARMACEUTICA LTDA
- Princípios ativos
- BESILATO DE ANLODIPINO;CLORIDRATO DE BENAZEPRIL
- Embalagem
- 5 MG + 20 MG CAP DURA CT BL AL PLAS TRANS X 30
- Tipo de produto
- Similar
- Classe terapêutica
- C9B3 - INIBIDORES DA ECA ASSOCIADOS A ANTAGONISTAS DO CÁLCIO (C8)
Nomes pelos quais este registro é encontrado
- PRESS PLUS 5 MG + 20 MG CAP DURA CT BL AL PLAS TRANS X 30
- PRESS PLUS
- BESILATO DE ANLODIPINO
- CLORIDRATO DE BENAZEPRIL
Dados completos da fonte
{
"name": "PRESS PLUS 5 MG + 20 MG CAP DURA CT BL AL PLAS TRANS X 30",
"holder": "BIOLAB SANUS FARMACEUTICA LTDA",
"stripe": null,
"barcodes": [
"7896112471165"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "504110909113312",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "49.475.833/0001-06",
"priceRegime": "Regulado",
"productName": "PRESS PLUS",
"productType": "Similar",
"hospitalOnly": false,
"presentation": "5 MG + 20 MG CAP DURA CT BL AL PLAS TRANS X 30",
"sourceStatus": null,
"supplyRegime": null,
"factoryPrices": {
"icms-0": "79.08",
"icms-12": "89.86",
"icms-17": "95.28",
"icms-18": "96.44",
"icms-19": "97.63",
"icms-20": "98.85",
"icms-21": "100.10",
"icms-22": "101.38",
"icms-23": "102.70",
"icms-17.5": "95.85",
"icms-19.5": "98.24",
"icms-20.5": "99.47",
"icms-22.5": "102.04",
"icms-12-alc": "88.79",
"icms-17-alc": "94.13",
"icms-18-alc": "95.28",
"icms-19-alc": "96.46",
"icms-20-alc": "97.66",
"icms-21-alc": "98.90",
"icms-22-alc": "100.17",
"icms-23-alc": "101.47",
"withoutTaxes": "78.13",
"icms-17.5-alc": "94.70",
"icms-19.5-alc": "97.06",
"icms-20.5-alc": "98.28",
"icms-22.5-alc": "100.81"
},
"pisCofinsList": "Positiva",
"substanceText": "BESILATO DE ANLODIPINO;CLORIDRATO DE BENAZEPRIL",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "109.00",
"icms-12": "123.86",
"icms-17": "131.33",
"icms-18": "132.93",
"icms-19": "134.57",
"icms-20": "136.25",
"icms-21": "137.98",
"icms-22": "139.74",
"icms-23": "141.56",
"icms-17.5": "132.12",
"icms-19.5": "135.41",
"icms-20.5": "137.11",
"icms-22.5": "140.65",
"icms-12-alc": "122.75",
"icms-17-alc": "130.13",
"icms-18-alc": "131.72",
"icms-19-alc": "133.35",
"icms-20-alc": "135.01",
"icms-21-alc": "136.72",
"icms-22-alc": "138.48",
"icms-23-alc": "140.28",
"withoutTaxes": "108.01",
"icms-17.5-alc": "130.92",
"icms-19.5-alc": "134.18",
"icms-20.5-alc": "135.87",
"icms-22.5-alc": "139.36"
},
"invalidBarcodes": [],
"activeSubstances": [
"BESILATO DE ANLODIPINO",
"CLORIDRATO DE BENAZEPRIL"
],
"therapeuticClass": "C9B3 - INIBIDORES DA ECA ASSOCIADOS A ANTAGONISTAS DO CÁLCIO (C8)",
"commercialisation": {
"year": 2025,
"marketed": true
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1097401450080",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "unknown",
"prescriptionRequired": null,
"therapeuticClassCode": "C9B3",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:504110909113312"